BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38493723)

  • 1. Notoginsenoside R1 alleviates cerebral ischemia/reperfusion injury by inhibiting the TLR4/MyD88/NF-κB signaling pathway through microbiota-gut-brain axis.
    Zhang S; Chen Q; Jin M; Ren J; Sun X; Zhang Z; Luo Y; Sun X
    Phytomedicine; 2024 Jun; 128():155530. PubMed ID: 38493723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the Combination of the Main Active Components of Astragalus and Panax notoginseng on Inflammation and Apoptosis of Nerve Cell after Cerebral Ischemia-Reperfusion.
    Huang XP; Ding H; Lu JD; Tang YH; Deng BX; Deng CQ
    Am J Chin Med; 2015; 43(7):1419-38. PubMed ID: 26477799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naotaifang III Protects Against Cerebral Ischemia Injury Through LPS/TLR4 Signaling Pathway in the Microbiota-Gut-Brain Axis.
    Nie H; Ge J; Yang K; Peng Z; Wu H; Yang T; Mei Z
    Drug Des Devel Ther; 2023; 17():3571-3588. PubMed ID: 38058793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qingda granule alleviates cerebral ischemia/reperfusion injury by inhibiting TLR4/NF-κB/NLRP3 signaling in microglia.
    Cai Q; Zhao C; Xu Y; Lin H; Jia B; Huang B; Lin S; Chen D; Jia P; Wang M; Lin W; Zhang L; Chu J; Peng J
    J Ethnopharmacol; 2024 Apr; 324():117712. PubMed ID: 38184025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory effects of quinolinyl analog of resveratrol targeting TLR4 in MCAO/R ischemic stroke rat model.
    Xu L; Mi Y; Meng Q; Liu Y; Wang F; Zhang G; Liu Y; Chen G; Hou Y
    Phytomedicine; 2024 Jun; 128():155344. PubMed ID: 38493721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMGB1-triggered inflammation inhibition of notoginseng leaf triterpenes against cerebral ischemia and reperfusion injury via MAPK and NF-κB signaling pathways.
    Xie W; Zhu T; Dong X; Nan F; Meng X; Zhou P; Sun G; Sun X
    Biomolecules; 2019 Sep; 9(10):. PubMed ID: 31547018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of breviscapine on cerebral ischemia-reperfusion injury and intestinal flora imbalance by regulating the TLR4/MyD88/NF-κB signaling pathway in rats.
    Chen HD; Jiang MZ; Zhao YY; Li X; Lan H; Yang WQ; Lai Y
    J Ethnopharmacol; 2023 Jan; 300():115691. PubMed ID: 36087844
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Zhang X; Zhang Q; Huang L; Liu M; Cheng Z; Zheng Y; Xu W; Lu J; Liu J; Huang M
    Pharm Biol; 2021 Dec; 59(1):828-839. PubMed ID: 34196587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notoginsenoside R1 intervenes degradation and redistribution of tight junctions to ameliorate blood-brain barrier permeability by Caveolin-1/MMP2/9 pathway after acute ischemic stroke.
    Liu B; Li Y; Han Y; Wang S; Yang H; Zhao Y; Li P; Wang Y
    Phytomedicine; 2021 Sep; 90():153660. PubMed ID: 34344565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesencephalic astrocyte-derived neurotrophic factor restores blood-brain barrier integrity of aged mice after ischaemic stroke/reperfusion through anti-inflammation via TLR4/MyD88/NF-κB pathway.
    Han D; Li F; Zhang H; Ji C; Shu Q; Wang C; Ni H; Zhu Y; Wang S
    J Drug Target; 2022 Apr; 30(4):430-441. PubMed ID: 34747270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvianolic acid A alleviated inflammatory response mediated by microglia through inhibiting the activation of TLR2/4 in acute cerebral ischemia-reperfusion.
    Ling Y; Jin L; Ma Q; Huang Y; Yang Q; Chen M; Shou Q
    Phytomedicine; 2021 Jul; 87():153569. PubMed ID: 33985878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginkgo diterpene lactones inhibit cerebral ischemia/reperfusion induced inflammatory response in astrocytes via TLR4/NF-κB pathway in rats.
    Li X; Huang L; Liu G; Fan W; Li B; Liu R; Wang Z; Fan Q; Xiao W; Li Y; Fang W
    J Ethnopharmacol; 2020 Mar; 249():112365. PubMed ID: 31678414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analgecine regulates microglia polarization in ischemic stroke by inhibiting NF-κB through the TLR4 MyD88 pathway.
    Yang C; Gong S; Chen X; Wang M; Zhang L; Zhang L; Hu C
    Int Immunopharmacol; 2021 Oct; 99():107930. PubMed ID: 34229178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-ischemia/reperfusion injury effects of notoginsenoside R1 on small molecule metabolism in rat brain after ischemic stroke as visualized by MALDI-MS imaging.
    Zhu T; Wang L; Tian F; Zhao X; Pu XP; Sun GB; Sun XB
    Biomed Pharmacother; 2020 Sep; 129():110470. PubMed ID: 32768957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective Effects of Ginsenosides against Cerebral Ischemia.
    Cheng Z; Zhang M; Ling C; Zhu Y; Ren H; Hong C; Qin J; Liu T; Wang J
    Molecules; 2019 Mar; 24(6):. PubMed ID: 30897756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irisin Protects Brain against Ischemia/Reperfusion Injury through Suppressing TLR4/MyD88 Pathway.
    Yu Q; Li G; Ding Q; Tao L; Li J; Sun L; Sun X; Yang Y
    Cerebrovasc Dis; 2020; 49(4):346-354. PubMed ID: 32756048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Danshen-Chuanxiongqin Injection attenuates cerebral ischemic stroke by inhibiting neuroinflammation via the TLR2/ TLR4-MyD88-NF-κB Pathway in tMCAO mice.
    Xu XJ; Long JB; Jin KY; Chen LB; Lu XY; Fan XH
    Chin J Nat Med; 2021 Oct; 19(10):772-783. PubMed ID: 34688467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notoginsenoside R1 activates the NAMPT-NAD
    Zhu T; Xie WJ; Wang L; Jin XB; Meng XB; Sun GB; Sun XB
    Biomed Pharmacother; 2021 Aug; 140():111693. PubMed ID: 34029951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [D-Ala
    Fu D; Liu H; Zhu J; Xu H; Yao J
    Mediators Inflamm; 2021; 2021():6661620. PubMed ID: 33628116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimally invasive vagus nerve stimulation modulates mast cell degranulation via the microbiota-gut-brain axis to ameliorate blood-brain barrier and intestinal barrier damage following ischemic stroke.
    Wang Y; Tan Q; Pan M; Yu J; Wu S; Tu W; Li M; Jiang S
    Int Immunopharmacol; 2024 May; 132():112030. PubMed ID: 38603861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.